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Abstract
Next-generation sequencing methods based on nanopore technology have recently gained
considerable attention, mainly because they promise affordable and fast genome sequencing by
providing long read lengths (5 kbp) and do not require additional DNA ampliﬁcation or
enzymatic incorporation of modiﬁed nucleotides. This permits health care providers and research
facilities to decode a genome within hours for less than $1000. This review summarizes past,
present, and future DNA sequencing techniques, which are realized by nanopore approaches
such as those pursued by Oxford Nanopore Technologies.
Keywords: nanopore sequencing, next generation sequencing, oxford nanopore technologies,
nanopore, sequencing
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DNA is the blueprint for all organisms. When a bacterium
acquires resistance to an antibiotic, or when a healthy cell
mutates into a tumor cell, it is due to changes in the DNA
sequences. If it were possible to swiftly sequence human,
bacterial, and viral genomes economically, health care would
experience a quantum leap in the diagnosis, understanding,
and treatment of diseases. For this reason, various techniques
for DNA sequencing have been developed since the early
1970s. Today the largest market for sequencing technologies
is the academic and corporate research environment, reaching
almost $1.4 billion US dollars. In particular, clinical appli-
cations for DNA sequencing are showing the fastest growth
(ﬁgure 1(a)) and could surpass the market for research
applications in a couple of years.
First- and second-generation sequencing methods
First-generation sequencing is based on the Sanger method,
which was presented in 1977 by the scientist Frederick Sanger
[1]. In this method, natural and chain-terminating nucleotides
are incorporated by a polymerase into a growing DNA chain
during replication. The random incorporation of chain-ter-
minating nucleotides, which are either ﬂuorescently or
radioactively labeled during the polymerase chain reaction
(PCR), leads to a population of DNA strands with different
lengths. These DNA strands are then separated according
their size by capillary electrophoresis. A laser combined with
a ﬂuorescence detector detects the ﬂuorescently labeled ter-
minated DNA when the molecules pass through the capillary
[2], which allows them to be sequenced. The maximum read
length of such fragments is about 1000 base pairs (bp).
Devices based on the Sanger sequencing method were the
main instruments used in the Human Genome Project, which,
in 2001, after a decade of multinational scientiﬁc cooperation
and a cost of about $3 billion, sequenced the entire human
genome [3].
The second generation of DNA sequencing instruments
works by detecting the incorporation of the labeled nucleo-
tides directly and prevents the necessity of separating the
DNA in a gel [4–6]. However, since earlier optical sensors
were not able to detect the incorporation of a single nucleo-
tide, a PCR step is still needed to amplify the DNA mole-
cules. This creates a large number of ﬂuorescently labeled
DNA molecules to generate enough photons to excite the
optical detectors. Second-generation instruments are sold by
companies such as 454 Life Sciences, Illumina, and Ion
Torrent [7]. Illumina, which was one of the ﬁrst next-gen-
eration device manufacturers, dominates today’s market
(ﬁgure 1(b)) with various machines such as MiSeq, GAIIx,
and HiSeq that target different customer needs such as cost
and device performance (ﬁgure 1(c)). The supremacy of
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Illumina is mainly due to its competitive cost per base per-
formance (ﬁgure 2(a)). Introduction of the second-generation
devices in 2007 considerably accelerated the reduction in the
cost-to-base ratio (dashed line in ﬁgure 2(a)).
Although these new techniques drove down costs and
time, their read length was lower (around 200 bp) than the
pioneering Sanger method, which reached up to 1000 bp
(ﬁgure 2(b)). Since most sequence targets are much longer than
200, the DNA has to be over-sequenced to generate enough
overlapping regions to merge the pieces for the entire
sequence. Because many genomes have already been decoded,
many projects require only sequencing of short segments,
rendering Illumina’s devices ideal for these kinds of tasks.
In 2008, a second-generation device from 454 Life Sci-
ences with an improved read length of about 800 bp managed
to sequence an entire human genome in a few weeks. This
improvement reduced the speed and costs for sequencing a
genome to about $1 million [8]. The last addition to the
market of second-generation sequencing instruments is man-
ufactured by Ion Torrent; this device is based on a similar
technique as 454 Life Sciences, but it senses the incorporation
of a nucleotide electrically by using a small, sensitive CMOS-
compatible pH meter [9]. Instead of detecting the incorpora-
tion of a nucleotide through a ﬂuorescent dye, the generation
of a hydrogen atom, which is released each time a nucleotide
is added into the growing strand, is probed. The pH meter
Figure 1. (a) Market size for DNA sequencing, divided into research and clinical applications. Clinical applications such as Down syndrome
testing for prenatal diagnostics were a late entry into the market due to regulatory hurdles but are predicted to display stronger market growth
to surpass the market for research applications in the DNA sequencing sector by 2017. (b) Currently the DNA sequencing device market is
dominated by Illumina, which owns approximately 65% of the market. At the same time, Ion Torrent has about 25% of the market, whereas
the rest is split between PacBio and 454 Life Sciences and also other, older, instrument manufacturers. (c) Cost as a function of the weight of
current and future DNA sequencing devices such as the MinION from ONT. PacBio RS represents the latest next-generation sequencing
instruments that are entering the market. Although devices from Illumina and Ion Torrent tend to occupy the middle range of this matrix,
devices from Oxford Nanopore Technologies might represent a quantum leap. Since the MinION is not yet commercially available, the size
and price presented here are estimates (hence the use of error bars). Although the error rate of the MinION might be high, its read length will
probably reach up to 20 kbp and will require only a USB port for its power supply.
Figure 2. (a) Cost per base of the different sequencing techniques as a function of time. The gray curve shows data calculated by the National
Human Genome Research Institute, United States, and represents the average costs, including reagents and instruments [38]. The introduction
of next-generation sequencing devices in 2007 has increased the rate of cost improvement. The blue, black, green, and magenta curves show
the decline in costs for the various NGS techniques such as 454 Life Sciences, Paciﬁc Biosystems, Ion Torrent, and Illumina, respectively. (b)
Read lengths plotted against time. The orange curve represents the original Sanger sequencing technique, which was ideal for de novo
genome sequencing tasks but is gradually being replaced by instruments from Paciﬁc Biosystems. Techniques from Ion Torrent and Illumina
cannot perform long read lengths but are proﬁtable due to their low cost-to-base ratio.
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chip replaces the camera and ﬂuorescent molecules in the 454
device and permits cheaper sequencing through lower reagent
and device costs. This advantage and an aggressive prize
strategy has enabled fast market penetration by Ion Torrent,
representing approximately 25% of all purchased instruments
(ﬁgure 1(b)).
Next-generation sequencing methods
The current next-generation sequencing (NGS) technologies
are deﬁned by several characteristics. First, they are able to
detect a single unmodiﬁed nucleotide by relying on new
optical and electrical single-molecule techniques. This avoids
the need for ampliﬁcation by PCR, thereby reducing time and
expenses for reagents. Another advantage lies in the extended
read length, which surpasses the 1000 bp limit, reaching up to
50 kbp; this reduces the need for over-sequencing to obtain
enough overlapping DNA sequences. Similar to the ﬁrst
feature, the increased read length also reduces the amount of
reagents and time needed to oversequence the DNA, thus
further driving costs down.
The ﬁrst next-generation sequencing instrument, devel-
oped by Paciﬁc Biosystems, is referred to as single-molecule
real-time sequencing (SMRT) and has been available since
2011. SMRT is based on a chip pioneered by Levene et al
[10] that contains an array of zero-mode waveguides
(ZMWs). A single DNA polymerase is attached to the bottom
of the well, and the ZMWs create an illuminated volume that
is small enough to observe the incorporation of a single
nucleotide [10]. Each time a nucleotide is added to the DNA
at the bottom of the well, the dye is detected before being
cleaved off and diffusing away. Although the devices are very
expensive (ﬁgure 1(c)), they are ideal for de novo sequencing
of unknown genomes due to their long read lengths of 8 kbp
(ﬁgure 2(b)). They even permit the quantiﬁcation of methy-
lation, DNA damage, and other epigenetic information [11].
Another NGS technique that is gaining much attention
recently is based on nanopores [12, 13]. The ﬁrst detection of
DNA using the biological nanopore α-hemolysin was
accomplished in 1996 by John Kasianowitz et al [14]. The
nanopore was incorporated into a phospholipid bilayer, which
separated two reservoirs ﬁlled with a KCl solution. Using two
electrodes placed on opposite sides of the bilayer, an electrical
potential can be applied, causing an ionic current. DNA,
which is negatively charged, can therefore be forced to
translocate through the nanopore by applying a positive
potential to the electrode on the opposite side of the mem-
brane. The translocation velocity varies, depending on para-
meters such as the electrical potential, the type of nanopore,
and whether the DNA is single-stranded or double-stranded
[15]. The optimal velocity is around 2 nucleotides per milli-
second, which will enable sequencing of a human genome in
8 h in a 10 × 10 array. During the translocation, the ionic
current is partially blocked, leading to a reduction in the
current and allowing differentiation between the four different
nucleotides [16, 17]. The amplitude and duration of these
blockades depend on the length and width of the translocating
polymer. Classical biological nanopores such as α-hemolysin
are only big enough to allow single-stranded DNA to pass
through, and they probe 10 to 12 nucleotides at a time
(ﬁgure 3(a)) [18]. Recent advances, such as the shorter and
narrower nanopore MspA, permit the identiﬁcation of four
nucleotides residing inside the nanopore by determining the
amount of blocked current (ﬁgure 3(b)). Combining the
MspA with the phi29 DNA polymerase can slow the trans-
location of DNA through the nanopore and subsequently
sequence 50-nt-long DNA fragments (ﬁgure 3(a)) [19].
Recent advances in signal processing have extended this
approach to 5-kilobase-long DNA strands [20]. Another cri-
tical parameter in this technique is the translocation velocity
[21], which has to be optimized to allow sufﬁcient time for
the acquisition of enough data points to determine the level
and hence the nucleotide. However, the velocity cannot be too
slow because it will result in a small throughput performance.
Oxford Nanopore Technologies (ONT) is developing a
device based on an array of biological nanopores as described
in ﬁgures 3(a) and (b) and launched a beta test at the begin-
ning of this year [22]. A commercial launch has not yet been
disclosed, but if the technology is coupled with a device that
enables reliable decoding of long sequences with an accep-
table error rate, it could change the current landscape of DNA
sequencing. In particular, the low cost and footprint (weight
and volume) could make these devices ideal for private users,
ﬁeld scientists in remote areas, and food processing industries
(ﬁgure 1(c)).
Figure 3. Scheme depicting the sequencing technique of Oxford
Nanopore Technologies. (a) Double-stranded DNA is separated into
single-stranded DNA by a polymerase such as phi29. This
decelerates the translocation velocity of the ssDNA through the
nanopore. The nanopore possesses a constriction inside the channel
(dark blue diamond), which enables reading of the ssDNA sequence.
(b) Simpliﬁed scheme depicting the decoding method. The ionic
current trace is altered by the ssDNA sequence translocating through
the nanopore, as shown in ﬁgure 3(a). Each level represents one
nucleotide residing inside the nanopore at a speciﬁc point in time. By
detecting these levels, the sequence of the DNA can be decoded. In
the current experiment, the nanopore is not sensitive enough to
detect one single nucleotide, but four nucleotides can increase the
number of levels to 256.
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Other nanopore developments concentrate largely on
solid-sate nanopores. Promising approaches are 2D materials
made out of graphene and molybdenum disulﬁde (MoS2)
made by exfoliation and chemical vapor deposition. Single-
layered 2D materials can reach a thinness of only 0.2 nm,
making them ideal candidates for interrogating single-stran-
ded DNA, whose bases are 0.34 nm apart. Although DNA
translocation through graphene nanopores was demonstrated
ﬁrst, the disadvantage of the technology was that the DNA
adhered to the nanopore and resulted in high background
noise [23–25]. A new 2D material is MoS2, which, can also
be manufactured in atom-thick layers and ﬁtted with a
nanopore. Previous work by Liu et al demonstrated that these
MoS2 nanopores have a much better signal-to-noise ratio
(amplitude of the current change caused by the DNA trans-
location divided by the noise of the current) of 15, compared
with 3.3 for graphene [26, 27]. However, to allow sequencing
of single-stranded DNA with these 2D materials, further noise
reduction has to be achieved by using materials such as quartz
substrates as supporting material [28, 29]. Moreover, since the
translocation velocity of dsDNA through solid-state nano-
pores is relatively high, strategies have to be tested to
decrease the translocation velocity. One approach could be to
increase viscosity by using high-viscosity media such as
glycerol or by using nanopore materials that slow transloca-
tion [30–32]. Other avenues envisage the combination of
solid-state nanopores with zero-mode waveguides to increase
the loading of the ZMWs with the DNA-protein complexes or
the integration of electrodes inside the nanopores to sequence
the DNA [33–35].
Future next-generation approaches for biological or
solid-state nanopores are being pursued by companies such as
Genia Technologies, Quantapore, Quantum Biosystems,
Base4, and Noblegen Biosciences [36]. Genia Technologies
was acquired by Roche in a deal surpassing $300 million,
attesting to the potential of the technique and interests from
larger pharmaceutical companies in the NGS ﬁeld. They aim
to combine biological nanopores with an optical detection
method. Quantum Biosystems is commercializing research by
Prof. T Kawai, who combined a tunneling electron detector
with a nanopore to sequence DNA [37]. Base4, on the other
hand, aims to cleave single nucleotides into droplets in a
water–oil emulsion and detect their presence by a chemical
cascade reaction. A different approach is being studied by the
group of Professor D Stein, which places a mass spectroscopy
instrument at the outlet of a nanopore to identify the cleaved
nucleotides by their size and charge.
Conclusion and outlook
Since the introduction of the Sanger sequencing method,
many new sequencing technologies have advanced read
length, increased bandwidth, and reduced costs. Companies
such as Paciﬁc Biosystems and 454 Life Sciences differ-
entiate themselves by allowing long read lengths and also
information about nucleotide modiﬁcations such as methyla-
tion. In contrast, companies like Illumina and Ion Torrent
attract customers with their low instrument price, user-
friendly sample preparation protocols, and low reagent costs,
which reduce the cost per base. Illumina even demonstrated
an instrument assembly that can sequence a human genome
for $1000. This, however, requires the acquisition of several
instruments, which can be used solely for sequencing large
genomes. New instruments such as those from Oxford
Nanopore Technologies offer a disruptive technology with
relatively high error rates but very low costs, lower power
requirements, and portability (ﬁgure 1(c)). This novel tech-
nology could tap into a brand-new sector of customers who
may require genetic ﬁngerprinting for fast identiﬁcation of
cancer types, pathogen and food safety.
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